Forms That Facilitate Patient Teaching

1979 ◽  
Vol 79 (7) ◽  
pp. 1227 ◽  
Author(s):  
Rebecca Whitehouse
Keyword(s):  
Patient Teaching

Patient teaching to promote behavioral change

2000 ◽  
Vol 48 (6) ◽  
pp. 281-287 ◽  
Author(s):  
Lembi Saarmann ◽  
JoAnn Daugherty ◽  
Barbara Riegel
Keyword(s):  
Behavioral Change ◽  
Patient Teaching

Patient teaching saves lives and money

Nursing ◽  
2005 ◽  
Vol 35 (4) ◽  
pp. 33-34
Author(s):  
&NA;
Keyword(s):  
Patient Teaching

The Effect of Patient Teaching on Compliance with Sick Role Behavior of diabetic Patients

1988 ◽  
Vol 18 (3) ◽  
pp. 281
Author(s):  
Oh Jang Park ◽  
Mi Soon Hong ◽  
Hyang Sook So ◽  
Kun Sung Jang
Keyword(s):  
Diabetic Patients ◽  
Sick Role ◽  
Role Behavior ◽  
Patient Teaching

SimBaby Plus Standardized Patient Teaching Model in the Teaching of Cases of Acute and Severe Bronchopneumonia in Infancy

2017 ◽  
Vol 33 (9) ◽  
pp. 630-634
Author(s):  
Wen Chuan ◽  
Xiong Jie ◽  
Wang Cheng ◽  
Wu Xiao-chuan ◽  
Mao Ding-an ◽  
...  
Keyword(s):  
Standardized Patient ◽  
Teaching Model ◽  
Patient Teaching

Patient - teaching aid

Nursing ◽  
1997 ◽  
Vol 27 (10) ◽  
pp. 32hh10
Author(s):  
&NA;
Keyword(s):  
Teaching Aid ◽  
Patient Teaching

USING ANALOGIES IN PATIENT TEACHING

1986 ◽  
Vol 86 (10) ◽  
pp. 1171-1172
Author(s):  
NANCY L. ELSBERRY ◽  
MARY ELLEN SORENSEN
Keyword(s):  
Patient Teaching

Lipid-lowering Drugs

1992 ◽  
Vol 3 (2) ◽  
pp. 494-506
Author(s):  
Melinda M. Milander ◽  
Merrily Kuhn
Keyword(s):  
National Cholesterol Education Program ◽  
Diet Therapy ◽  
Lipid Lowering ◽  
Lipid Uptake ◽  
Pharmaceutical Treatment ◽  
General Reference ◽  
Treatment And Prevention ◽  
Patient Teaching ◽  
Artery Disease ◽  
Lipid Lowering Agents

Controlling hyperlipidemia is an important aspect in the treatment and prevention of coronary artery disease. This article provides the clinician with a general reference for currently used lipid-lowering agents. Lipoproteins present in the plasma are defined and a brief overview of their functions is presented. Normal lipid uptake from the intestine and normal lipid metabolism are discussed to provide a basis for an understanding of the pharmaceutical treatment of hyperlipidemia. Guidelines are reviewed for interpreting lipid profiles according to the National Cholesterol Education Program. An evaluation of the agents currently used to treat hyperlipidemia is included. Lipid-lowering agents cause alterations in liver function; therefore, patients taking these medications are monitored closely. Patient teaching, including adverse effects of the medications, diet therapy and other alterable risk factors, is also reviewed

Sign in / Sign up

Export Citation Format

Share Document